
### [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518)
**Label:** isolated punctate palmoplantar keratoderma

**Subclasses:** [MONDO:0013980](http://purl.obolibrary.org/obo/MONDO_0013980) (PPKP1B), [MONDO:0014574](http://purl.obolibrary.org/obo/MONDO_0014574) (peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome), [MONDO:0008292](http://purl.obolibrary.org/obo/MONDO_0008292) (punctate palmoplantar keratoderma type 2), [MONDO:0017677](http://purl.obolibrary.org/obo/MONDO_0017677) (focal acral hyperkeratosis), [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), [MONDO:0007047](http://purl.obolibrary.org/obo/MONDO_0007047) (punctate palmoplantar keratoderma type III), [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), [MONDO:0007858](http://purl.obolibrary.org/obo/MONDO_0007858) (palmoplantar keratoderma, punctate type 1A), [MONDO:0008291](http://purl.obolibrary.org/obo/MONDO_0008291) (porokeratosis plantaris palmaris et disseminata), 

**Mapped go classes:** [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007343](http://purl.obolibrary.org/obo/GO_0007343) (egg activation), [GO:0097340](http://purl.obolibrary.org/obo/GO_0097340) (inhibition of cysteine-type endopeptidase activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity), [GO:0043086](http://purl.obolibrary.org/obo/GO_0043086) (negative regulation of catalytic activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0071157](http://purl.obolibrary.org/obo/GO_0071157) (negative regulation of cell cycle arrest), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0010859](http://purl.obolibrary.org/obo/GO_0010859) (calcium-dependent cysteine-type endopeptidase inhibitor activity), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:2000675](http://purl.obolibrary.org/obo/GO_2000675) (negative regulation of type B pancreatic cell apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), 

**Class expressions from DL-Learner:**

- [GO:0010859](http://purl.obolibrary.org/obo/GO_0010859) (calcium-dependent cysteine-type endopeptidase inhibitor activity) 60.00%
- Thing 51.43%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 45.36%
- [GO:0004869](http://purl.obolibrary.org/obo/GO_0004869) (cysteine-type endopeptidase inhibitor activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000695](http://purl.obolibrary.org/obo/GO_2000695) (null)) 45.36%


